Advertisement
Opinion
From obesity to diabetes, China cannot afford to put its epidemic of chronic diseases on the back burner
- Efforts to tackle the escalating prevalence in non-communicable diseases, the leading cause of deaths, were waylaid, first by Covid-19, then the economic slowdown
- Beyond the health crisis of an overweight, disproportionately diabetic population with rising cardiovascular deaths is a brewing social crisis as health budgets are strained
4-MIN READ4-MIN
3

Yanzhong Huang is a senior fellow for global health at the Council on Foreign Relations, and a professor at the School of Diplomacy and International Relations, Seton Hall University.
Like many visitors to China, I was enticed by its delectable cuisine. “You seem to have had a change in body shape,” a friend teased. Upon returning to the US, I was astonished to learn I had put on 7lbs (3.2kg) in a mere three weeks.
As I strive to shed those pounds on the treadmill, I reflect on the health implications for those in China facing the allure of a rich diet laden with salt, sugar and fat – the leading risk factors for obesity, cardiovascular diseases, diabetes and cancer.
A recent report from the second China Obesity Congress in Beijing underlined my concerns about China’s escalating obesity problem. The five-year study, encompassing data from more than 20 provinces and cities, noted that the number of patients undergoing weight loss and metabolic surgeries reached 10,000 in the three years from 2019 to 2021.
Alarmingly, it took only one year, from 2021 to 2022, to reach the next 10,000. This trend aligns with a National Health Commission report, which showed adult obesity rates had more than doubled from 7.1 per cent in 2002 to 16.4 per cent in 2020. The report further indicated that over half of adults, or more than half a billion people, in China were overweight.
Select Voice
Select Speed
1x
AI-generated voice
